These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19138936)

  • 1. A prediction model for lung cancer diagnosis that integrates genomic and clinical features.
    Beane J; Sebastiani P; Whitfield TH; Steiling K; Dumas YM; Lenburg ME; Spira A
    Cancer Prev Res (Phila); 2008 Jun; 1(1):56-64. PubMed ID: 19138936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer.
    Spira A; Beane JE; Shah V; Steiling K; Liu G; Schembri F; Gilman S; Dumas YM; Calner P; Sebastiani P; Sridhar S; Beamis J; Lamb C; Anderson T; Gerry N; Keane J; Lenburg ME; Brody JS
    Nat Med; 2007 Mar; 13(3):361-6. PubMed ID: 17334370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
    Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
    BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
    Pavel AB; Campbell JD; Liu G; Elashoff D; Dubinett S; Smith K; Whitney D; Lenburg ME; Spira A;
    Cancer Prev Res (Phila); 2017 Nov; 10(11):651-659. PubMed ID: 28877936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
    Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
    J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
    AEGIS Study Team
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
    Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
    BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection.
    Billatos E; Vick JL; Lenburg ME; Spira AE
    Clin Cancer Res; 2018 Jul; 24(13):2984-2992. PubMed ID: 29463557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
    Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
    Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
    N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
    Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
    J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
    Singal G; Miller PG; Agarwala V; Li G; Kaushik G; Backenroth D; Gossai A; Frampton GM; Torres AZ; Lehnert EM; Bourque D; O'Connell C; Bowser B; Caron T; Baydur E; Seidl-Rathkopf K; Ivanov I; Alpha-Cobb G; Guria A; He J; Frank S; Nunnally AC; Bailey M; Jaskiw A; Feuchtbaum D; Nussbaum N; Abernethy AP; Miller VA
    JAMA; 2019 Apr; 321(14):1391-1399. PubMed ID: 30964529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
    Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
    Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
    Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
    J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
    J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
    Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.
    Voss JS; Iqbal S; Jenkins SM; Henry MR; Clayton AC; Jett JR; Kipp BR; Halling KC; Maldonado F
    Hum Pathol; 2014 Jan; 45(1):41-7. PubMed ID: 24139213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer.
    Jiang J; Jin Z; Zhang Y; Peng L; Zhang Y; Zhu Z; Wang Y; Tong D; Yang Y; Wang J; Yang Y; Xiao K
    Front Immunol; 2021; 12():646874. PubMed ID: 33927719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.